Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2006 1
2007 1
2008 1
2010 1
2011 3
2012 6
2013 1
2014 2
2015 1
2016 1
2017 1
2018 1
2021 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

17 results
Results by year

Citations

1 article found by citation matching

Search results

Filters applied: . Clear all
Page 1
Detecting Genetic Mosaicism in Cultures of Human Pluripotent Stem Cells.
Baker D, Hirst AJ, Gokhale PJ, Juarez MA, Williams S, Wheeler M, Bean K, Allison TF, Moore HD, Andrews PW, Barbaric I. Baker D, et al. Stem Cell Reports. 2016 Nov 8;7(5):998-1012. doi: 10.1016/j.stemcr.2016.10.003. Stem Cell Reports. 2016. PMID: 27829140 Free PMC article.
Genetic changes in human pluripotent stem cells (hPSCs) gained during culture can confound experimental results and potentially jeopardize the outcome of clinical therapies. ...Our analysis highlights the limits of mosaicism det
Genetic changes in human pluripotent stem cells (hPSCs) gained during culture can confound experim
The Impact of Acquired Genetic Abnormalities on the Clinical Translation of Human Pluripotent Stem Cells.
Keller A, Spits C. Keller A, et al. Cells. 2021 Nov 19;10(11):3246. doi: 10.3390/cells10113246. Cells. 2021. PMID: 34831467 Free PMC article. Review.
Human pluripotent stem cells (hPSC) are known to acquire chromosomal abnormalities, which range from point mutations to large copy number changes, including full chromosome aneuploidy. ...A further complication is that many of these abnormalities exist
Human pluripotent stem cells (hPSC) are known to acquire chromosomal abnormalities, which range from point mutat
Somatic copy number mosaicism in human skin revealed by induced pluripotent stem cells.
Abyzov A, Mariani J, Palejev D, Zhang Y, Haney MS, Tomasini L, Ferrandino AF, Rosenberg Belmaker LA, Szekely A, Wilson M, Kocabas A, Calixto NE, Grigorenko EL, Huttner A, Chawarska K, Weissman S, Urban AE, Gerstein M, Vaccarino FM. Abyzov A, et al. Nature. 2012 Dec 20;492(7429):438-42. doi: 10.1038/nature11629. Epub 2012 Nov 18. Nature. 2012. PMID: 23160490 Free PMC article.
Reprogramming somatic cells into induced pluripotent stem cells (iPSCs) has been suspected of causing de novo copy number variation. ...Overall, we estimate that approximately 30% of the fibroblast cells have somatic CNVs in their genomes, sugge …
Reprogramming somatic cells into induced pluripotent stem cells (iPSCs) has been suspected of causing de novo co …
Screening of human pluripotent stem cells using CGH and FISH reveals low-grade mosaic aneuploidy and a recurrent amplification of chromosome 1q.
Dekel-Naftali M, Aviram-Goldring A, Litmanovitch T, Shamash J, Reznik-Wolf H, Laevsky I, Amit M, Itskovitz-Eldor J, Yung Y, Hourvitz A, Schiff E, Rienstein S. Dekel-Naftali M, et al. Eur J Hum Genet. 2012 Dec;20(12):1248-55. doi: 10.1038/ejhg.2012.128. Epub 2012 Jun 20. Eur J Hum Genet. 2012. PMID: 22713809 Free PMC article.
Pluripotency and proliferative capacity of human embryonic stem cells (hESCs) make them a promising source for basic and applied research as well as in therapeutic medicine. The introduction of human induced pluripotent cells (hiPSCs) hol …
Pluripotency and proliferative capacity of human embryonic stem cells (hESCs) make them a promising source for basic an …
Low-grade chromosomal mosaicism in human somatic and embryonic stem cell populations.
Jacobs K, Mertzanidou A, Geens M, Nguyen HT, Staessen C, Spits C. Jacobs K, et al. Nat Commun. 2014 Jun 27;5:4227. doi: 10.1038/ncomms5227. Nat Commun. 2014. PMID: 24970340 Free article.
Here we study the genetic content of 92 individual human cells, including fibroblasts, amniocytes and embryonic stem cells (hESCs), using single-cell array-based comparative genomic hybridization (aCGH). We find that human somatic and emb …
Here we study the genetic content of 92 individual human cells, including fibroblasts, amniocytes and embryonic stem
Origins and rates of aneuploidy in human blastomeres.
Rabinowitz M, Ryan A, Gemelos G, Hill M, Baner J, Cinnioglu C, Banjevic M, Potter D, Petrov DA, Demko Z. Rabinowitz M, et al. Fertil Steril. 2012 Feb;97(2):395-401. doi: 10.1016/j.fertnstert.2011.11.034. Epub 2011 Dec 21. Fertil Steril. 2012. PMID: 22195772
DESIGN: Analysis of blastomeres biopsied from cleavage-stage embryos for preimplantation genetic screening during IVF. SETTING: Laboratory. PATIENT(S): Couples undergoing IVF treatment. ...MAIN OUTCOME MEASURE(S): Chromosomal error types (monosomy vs. trisomy …
DESIGN: Analysis of blastomeres biopsied from cleavage-stage embryos for preimplantation genetic screening during IVF. SETTING: Labor …
Derivation of euploid human embryonic stem cells from aneuploid embryos.
Lavon N, Narwani K, Golan-Lev T, Buehler N, Hill D, Benvenisty N. Lavon N, et al. Stem Cells. 2008 Jul;26(7):1874-82. doi: 10.1634/stemcells.2008-0156. Epub 2008 May 1. Stem Cells. 2008. PMID: 18450823 Free article.
Human embryonic stem cells (HESCs) are pluripotent cells derived from the inner cell mass of preimplantation embryos. ...Alternatively, we suggest that the euploid HESC lines originated from mosaic embryos consisting of aneuploid and eupl
Human embryonic stem cells (HESCs) are pluripotent cells derived from the inner cell mass of preimplantat
Somatic mosaicism containing double mutations in PTCH1 revealed by generation of induced pluripotent stem cells from nevoid basal cell carcinoma syndrome.
Ikemoto Y, Takayama Y, Fujii K, Masuda M, Kato C, Hatsuse H, Fujitani K, Nagao K, Kameyama K, Ikehara H, Toyoda M, Umezawa A, Miyashita T. Ikemoto Y, et al. J Med Genet. 2017 Aug;54(8):579-584. doi: 10.1136/jmedgenet-2016-104490. Epub 2017 Mar 31. J Med Genet. 2017. PMID: 28363938
METHODS AND RESULTS: A de novo germline mutation of PTCH1 (c.272delG) was detected in a 31-year-old woman with NBCCS. Gene analysis of two out of four induced pluripotent stem cell (iPSC) clones established from the patient unexpectedly revealed an additional …
METHODS AND RESULTS: A de novo germline mutation of PTCH1 (c.272delG) was detected in a 31-year-old woman with NBCCS. Gene analysis o …
Genetic and epigenetic X-chromosome variations in a parthenogenetic human embryonic stem cell line.
Liu W, Yin Y, Jiang Y, Kou C, Luo Y, Huang S, Zheng Y, Li S, Li Q, Guo L, Gao S, Sun X. Liu W, et al. J Assist Reprod Genet. 2011 Apr;28(4):303-13. doi: 10.1007/s10815-010-9517-1. Epub 2010 Dec 15. J Assist Reprod Genet. 2011. PMID: 21161365 Free PMC article.
PURPOSE: To assess the genetic and epigenetic status of parthenogenetic human embryonic stem cells (phESCs). ...After being cultured long term in vitro, some cells lost one X, and the proportion of cells with only one X gradually i …
PURPOSE: To assess the genetic and epigenetic status of parthenogenetic human embryonic stem cells (phESCs). ... …
In vivo differentiated human embryonic stem cells can acquire chromosomal aberrations more frequently than in vitro during the same period.
Zucchelli M, Ström S, Holm F, Malmgren H, Sahlén S, Religa P, Hovatta O, Kere J, Inzunza J. Zucchelli M, et al. Stem Cells Dev. 2012 Dec 10;21(18):3363-71. doi: 10.1089/scd.2012.0066. Epub 2012 Aug 3. Stem Cells Dev. 2012. PMID: 22709429
Human embryonic stem cells (hESCs) are regarded as a promising approach to generate transplantable cells for the treatment of several diseases. ...In the hESC line HS364 differentiated in vivo, an amplification of the whole X chromosome was detected
Human embryonic stem cells (hESCs) are regarded as a promising approach to generate transplantable cells for the
17 results